Skip to main content Skip to search Skip to main navigation
Go to homepage

Seraseq® Antepartum 22q11 Male cfDNA

Product information "Seraseq® Antepartum 22q11 Male cfDNA"

Seraseq® Antepartum 22q11 Male cfDNA is a reference material for non-invasive prenatal testing (NIPT) of the 22q11 fetal microdeletion in pregnant patients via cell-free DNA (cfDNA) analysis. This product is derived from a naturally-occurring mixture of maternal and fetal circulating cell-free DNA in a pregnant donor’s prenatal blood sample whose male fetus has been diagnosed with a 22q11 microdeletion (DiGeorge Syndrome). The native cfDNA characteristics such as size profile of ~170 bp, SNP content and natural maternal-fetal size difference are preserved. This product is designed for use in NGS, PCR or microarray-based NIPT assays in steps that follow cfDNA isolation; and no further purification or DNA isolation is needed.
Product type: Control & reference materials
Regulatory status: RUO
Content: 1 x 25 µl
Storage temperature: -20 °C
Shipping method: Dry ice
Country of distribution: Germany, Austria
Questions?
Get in touch with us. We look forward to helping you.
Seraseq® Antepartum 22q11 Male cfDNA
€877.00*